CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| University of California, Los Angeles |
Dr. Yong Kim |
Basic Biology II |
Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells |
$1,259,371 |
| University of California, San Diego |
Dr. Kun-Liang Guan |
Basic Biology II |
The function of YAP in human embryonic stem cells |
$1,245,693 |
| Stanford University |
Dr. Aaron J Hsueh |
Basic Biology II |
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation |
$1,309,018 |
| University of California, San Francisco |
Dr. John L Rubenstein |
Basic Biology II |
MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells |
$1,387,800 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Huei-sheng Vincent Chen |
Basic Biology II |
Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes |
$1,587,610 |
| University of California, Irvine |
Dr. Aileen J Anderson |
Basic Biology II |
Role of the microenvironment in human iPS and NSC fate and tumorigenesis |
$1,256,194 |
| Stanford University |
Dr. Steven Edward Artandi |
Basic Biology II |
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease |
$931,285 |
| Salk Institute for Biological Studies |
Ronald Mark Evans |
Basic Biology II |
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
| Calimmune, Inc. |
Geoff Symonds |
Disease Team Research I |
GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE |
$8,278,722 |
| Stanford University |
Dr. Gary Steinberg |
Disease Team Research I |
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke |
$17,244,851 |
| University of California, San Diego |
Dr. Lawrence S. B. Goldstein |
Disease Team Research I |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$5,694,308 |
| University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Disease Team Research I |
Stem Cell Gene Therapy for Sickle Cell Disease |
$8,833,695 |
| University of California, Los Angeles |
Dr. Irvin SY Chen |
Disease Team Research I |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$9,905,604 |
| ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$0 |
| Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
| University of California, San Francisco |
Dr. Mitchel S Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$6,214,914 |
| City of Hope, Beckman Research Institute |
Prof. Karen S Aboody M.D. |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$17,890,623 |
| Stanford University |
Dr. Alfred T Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,039,208 |
| Stanford University |
Professor Irving L Weissman MD |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
| University of California, Los Angeles |
Dr. Dennis J Slamon |
Disease Team Research I |
Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors |
$19,979,660 |
| City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Disease Team Research I |
ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS |
$14,536,969 |
| University of Southern California |
Dr. Mark S Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
| University of California, San Diego |
Dr. Dennis A Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
| University of California, San Diego |
Gene Wei-Ming Yeo |
Basic Biology I |
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency |
$1,308,901 |
| University of California, San Diego |
Karl H. Willert |
Basic Biology I |
WNT signaling and the control of cell fate decisions in human pluripotent stem cells. |
$1,329,298 |
| University of California, Davis |
Dr. Min Zhao |
Basic Biology I |
Directing migration of human stem cells with electric fields |
$816,228 |
| University of California, Los Angeles |
Dr. Michael A. Teitell |
Basic Biology I |
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer |
$1,323,029 |
| University of Southern California |
Dr. Martin Pera |
Basic Biology I |
The stem cell microenvironment in the maintenance of pluripotency and reprogramming |
$1,325,723 |
| Stanford University |
Dr. Julien Sage |
Basic Biology I |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,357,085 |
| Stanford University |
Dr. Susan K McConnell |
Basic Biology I |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,404,853 |
| University of California, Los Angeles |
Dr. Bennett G Novitch Ph.D. |
Basic Biology I |
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons |
$1,228,278 |
| University of California, Los Angeles |
Dr. Robb Maclellan Dr. |
Basic Biology I |
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate |
$917,667 |
| University of Southern California |
Dr. Wange Lu |
Basic Biology I |
Defining the molecular mechanisms of somatic cell reprogramming |
$1,365,580 |
| Stanford University |
Dr. Helen M Blau |
Basic Biology I |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,408,332 |
| University of California, Los Angeles |
Dr. Luisa Iruela-Arispe |
Basic Biology I |
Molecular Characterization and Functional Exploration of Hemogenic Endothelium |
$1,371,477 |
| University of California, San Diego |
Jonathan Sebat |
ReMIND – Discovery Stage ReMIND |
Modeling the genetic basis of psychopathology in schizophrenia and autism |
$12,703,708 |
| University of California, San Francisco |
Tomasz Nowakowski |
ReMIND – Discovery Stage ReMIND |
CIRM Center for Neuropsychiatric Stem Cell Proteomics |
$13,781,522 |
| Scripps Research Institute |
Xin Jin |
ReMIND – Discovery Stage ReMIND |
Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo |
$11,376,314 |
| Scripps Research Institute |
Stuart A Lipton |
ReMIND – Discovery Stage ReMIND |
Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD) |
$17,365,387 |
| University of California, San Francisco |
Alex Pollen |
ReMIND – Discovery Stage ReMIND |
Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments |
$12,297,272 |
| University of Southern California |
Dr. Francesca Mariani |
Conference – 2024 CIRM Trainee Network Conference |
Manage the 2024 CIRM Annual Trainee Network Conference |
$400,000 |
| EVERSANA |
Abbi Kalb |
Patient Support Program |
Patient Support Program to Improve Accessibility to Eligible CIRM-Trial Patients |
$2,485,000 |
| Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
Shared Labs Grant – Enhancing/Expanding SRLs |
A Center for Stem Cell Disease Modeling and Therapeutics |
$4,000,000 |
| Cedars-Sinai Medical Center |
Arun Sharma |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resource Laboratory for Advanced Stem Cell-Based Modeling |
$3,999,995 |
| University of California, Santa Barbara |
Dr. Dennis O. Clegg Dr. |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resources Laboratory for Stem Cell-Based Modeling in Stem Cell Biology and Engineering |
$3,991,879 |
| Salk Institute for Biological Studies |
Dr. Fred H Gage |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resource Laboratory for Stem Cell-Based Modeling: Resources for Exploring the Biological Underpinnings of Aging and Age-Associated Pathologies |
$3,641,064 |
| University of Southern California |
Dr. Nils O. Lindstrom |
Shared Labs Grant – Enhancing/Expanding SRLs |
CIRM ASCEND Center – Advancing Stem Cell Education and Novel Discoveries |
$3,663,163 |
| University of California, Los Angeles |
Dr. Kathrin Plath Dr. |
Shared Labs Grant – Enhancing/Expanding SRLs |
A modular automation approach to stem cell modeling to increase throughput, reproducibility and access |
$3,999,999 |
| University of California, Irvine |
Craig M. Walsh |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resources Laboratories to Enhance In Vitro Stem Cell Modeling and Training |
$3,641,396 |
| Humboldt State University Sponsored Programs Foundation |
Dr Amy Sprowles |
Shared Labs Grant – Establishing SRLs |
Cal Poly Humboldt Shared Resource Laboratory for Human Stem Cell-Based Modeling (SRL-hSC) |
$4,399,888 |
